|
Checkpoint Inhibitor, Immune Clinical Trials
2 actively recruiting trials across 2 locations
Pipeline
Phase 2: 1
Top Sponsors
- VastBiome1
- EpicentRx, Inc.1
Indications
- Cancer2
- Non-Small Cell Lung Carcinoma1
- Sarcoma,Soft Tissue1
- Renal Cell Carcinoma1
- Malignant Melanoma1
Duarte, California1 trial
Phase 2
Elizabethtown, Kentucky1 trial
The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors
Baptist Health Clinical Research
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.